Endovascular Aneurysm Repair Devices Market

Endovascular Aneurysm Repair Devices Market by Indication (Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA), and Thoracoabdominal Aortic Aneurysm (TAAA)), Product (Aortic Stents, Thoracic Aortic Aneurysm Grafts, and Others), Site (Infrarenal and Pararenal), End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing incidence of abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA), increasing preference for minimally invasive surgical procedures, and increase in product development activities across the globe.

The endovascular aneurysm repair devices market was valued at USD 2,937.61 million in 2024, growing at a CAGR of 5.85% during the forecast period from 2025 to 2032, to reach USD 4,613.26 million by 2032. The rising incidence of abdominal and thoracic aortic aneurysms (AAA and TAA) is significantly driving the Endovascular Aneurysm Repair (EVAR) market. As the aging population grows, demand for effective, minimally invasive treatments like EVAR increases, given its benefits of reduced hospitalization, lower complication rates, and quicker recovery compared to traditional surgery. Additionally, continuous advancements in EVAR device technology, such as more flexible stent grafts and improved imaging for precise placement, are expanding its applicability to a broader range of patients, further boosting market growth. Together, these factors are expected to increase the demand for endovascular aneurysm repair devices across the globe during the forecast period from 2025 to 2032.

Endovascular Aneurysm Repair Devices Market Dynamics:

As per the recent data and stats provided by Government UK (2023), approximately, 1,794 individuals, were suffering from aneurysms (aorta measuring more than or equal to 3.0cm) in the UK.

Additionally, as per the data and stats provided by DelveInsight, the total abdominal aortic aneurysms diagnosed prevalent population in 7MM was estimated to be 1,641,380 cases in 2021. Among the EU-5 countries, the total abdominal aortic aneurysms prevalent population is highest in Germany (192,532), followed by France (138,193), and Italy (68,202) had the lowest prevalent cases among the EU-5 countries. Thus, the rise in AAA cases naturally leads to a higher demand for EVAR devices, as they provide a safer and more efficient treatment method compared to traditional surgery. EVAR offers a minimally invasive alternative, where a stent graft is delivered through small incisions in the groin and guided to the aneurysm site within the aorta. This procedure significantly reduces the trauma associated with surgery, lowers the risk of complications, and shortens recovery time, making it a preferred option for both patients and healthcare providers and thereby escalating the overall market across the globe.

Furthermore, according to the recent facts provided by the Centre for Disease Control and Prevention (2024), smoking accounts for about 75% of all abdominal aortic aneurysms.

Moreover, according to the recent stats and data provided by the World Health Organization (2023), around 80% of the world population smokes tobacco products. As smoking is a major risk factor for AAA, the high prevalence of smoking globally translates into a larger population at risk for developing this life-threatening condition. This, in turn, is likely to drive increased demand for endovascular aneurysm repair (EVAR) devices, as more individuals will require intervention to treat these aneurysms. The widespread smoking-related risk increases the incidence of aneurysms, leading to a greater need for minimally invasive solutions like EVAR, which are preferred due to their reduced recovery times and lower complication rates compared to traditional open surgery.

Furthermore, the significance of key market players involved in strategic product development activities is further boosting the overall market of endovascular aneurysm repair devices. For instance, in September 2023, MicroPort announced that its Castor™ branched Aortic Stent-Graft and Delivery System, Minos™ Abdominal Aortic Stent-Graft and Delivery System, and Hercules™ Thoracic Stent Graft System with Low Profile Delivery System, developed by Endovastec™, were granted registration approval by the Thailand Food and Drug Administration (TFDA). These three products were key offerings from Endovastec™ for endovascular intervention in thoracic and abdominal aortic diseases.

Thus, the factors mentioned above are likely to boost the market for endovascular aneurysm repair devices during the forecasted period.

However, the complications and risks associated with endovascular aneurysm repair devices such as endoleaks where blood continues to flow into the aneurysm sac, limited access in small vessels, and others, and stringent regulatory concerns may hinder the future market of endovascular aneurysm repair devices.

Endovascular Aneurysm Repair Devices Market Segment Analysis:

Endovascular Aneurysm Repair Devices Market by Indication (Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA), and Thoracoabdominal Aortic Aneurysm (TAAA)), Product (Aortic Stents, Thoracic Aortic Aneurysm Grafts, and Others), Site (Infrarenal and Pararenal), End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the indication segment of the endovascular aneurysm repair devices market, abdominal aortic aneurysm (AAA) is expected to hold a significant revenue share in the year 2024. As the global population continues to age, the prevalence of AAA is increasing, particularly among older adults who are more prone to arterial weakening due to factors like hypertension, atherosclerosis, and smoking. This growing patient population is fueling the demand for effective treatment options, making EVAR an increasingly preferred choice. EVAR offers a minimally invasive alternative that significantly reduces hospital stays, lowers the risk of complications, and enables quicker recovery. These advantages are particularly appealing to both patients and healthcare providers, especially for high-risk individuals who may not be ideal candidates for open surgery.

Moreover, the market is being further boosted by advancements in EVAR technology, which have made the procedure safer and more accessible to a broader range of patients. Innovations such as more flexible and durable stent-grafts, enhanced imaging techniques for precise graft placement, and improved delivery systems are expanding the applicability of EVAR, including in patients with challenging anatomies that were previously unsuitable for this approach. Additionally, the continuous improvement in post-procedural outcomes, such as reduced incidences of endoleaks and graft migration, has strengthened the confidence of both surgeons and patients in choosing EVAR over traditional methods. For instance, in March 2023, Viz.ai announced that it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its algorithm for detecting suspected abdominal aortic aneurysms (AAAs). Viz. AAA became the first FDA-cleared AI solution for detecting and classifying suspected AAAs.

Thus, owing to the above-mentioned factors the segment is expected to generate considerable revenue thereby pushing the overall growth of the global endovascular aneurysm repair devices market during the forecast period.

North America is expected to dominate the overall endovascular aneurysm repair devices market:

Among all the regions, North America is expected to hold the largest share in the endovascular aneurysm repair device market in 2024. This dominance is driven by the rising cases of abdominal and thoracic aneurysms, increasing cases of hypertension, smoking, and atherosclerosis, increasing adoption of minimally invasive procedures, increased healthcare initiatives by government and key market players involved in strategic activities, and the heightened awareness among the population across the region are expected to boost the market during the forecast period across the region.

According to the latest data provided by the Centre for Disease Control and Prevention (2024), the number of visits to physician offices with coronary atherosclerosis and other chronic ischemic heart disease as the primary diagnosis was 13.0 million in the United States.

Additionally, according to the recent data and stats provided by DelveInsight, abdominal aortic aneurysms diagnosed with prevalent cases in the US were estimated to be 752,408 in 2021. In the US, the highest number of cases were found to be having Small Abdominal Aortic Aneurysms (3 cm to 4.4 cm across) (696,730 cases) in 2021. Large Abdominal Aortic Aneurysms (5.5 cm or more across) were found in the least number of cases, i.e. 3,010 cases in 2021. Around 60,193 cases had Medium Abdominal Aortic Aneurysm (4.5 cm to 5.4 cm across) in 2021. These cases are expected to increase in the forecast period.

Thus, this growing patient population is creating an urgent need for effective and less invasive treatment options. EVAR offers a minimally invasive alternative to traditional open surgery, which involves substantial risks and longer recovery times. The advantages of EVAR, such as reduced hospital stays, lower complication rates, and quicker recovery, make it an increasingly preferred option among both patients and healthcare providers thereby boosting the market across the region.

Further, rising product launches and approvals activities by key market players for the treatment of endovascular aneurysm repair devices in the United States are expected to drive the market growth of endovascular aneurysm repair devices. For instance, in December 2022, the FDA approved new labeling for the currently available product, the AFX2 Endovascular AAA System (AFX2), that includes information to better inform patients and healthcare providers of the risk of Type III endoleaks.

Thus, all the above-mentioned factors are anticipated to propel the market for endovascular aneurysm repair devices in North America during the forecast period from 2025 to 2032.

Endovascular Aneurysm Repair Devices Market Key Players:

Some of the key market players operating in the endovascular aneurysm repair devices market include Medtronic PLC, Cook, W.L. Gore & Associates, Inc., Terumo Corporation, Endologix LLC., MicroPort Scientific Corporation, Lombard Medical, Viz.ai, Cardinal Health Inc., Cordis Corporation, Koninklijke Philips N.V., Becton, Dickinson and Company, Endoron Medical Ltd., Abbott, Getinge AB, and others.

Recent Developmental Activities in the Endovascular Aneurysm Repair Devices Market:

• In April 2025, Gore announced the expansion of its Gore Tag conformable thoracic stent graft with Active Control system, following FDA approval of four new large-diameter tapered sizes: 34x28mm, 37x31mm, 40x34mm, and 45x37mm.
• In March 2025, the U.S. Food & Drug Administration announced that Philips has removed and discontinued the distribution of the Tack Endovascular System due to reported challenges experienced by users.
• In January 2024, W. L. Gore & Associates (Gore) announced FDA approval for the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE), the first off-the-shelf endovascular solution for the treatment of complex aneurysmal disease involving the visceral aorta.
• In May 2023, Terumo Corporation announced that the US Food and Drug Administration (FDA) granted approval of the Relay®Pro Thoracic Stent-Graft device for the treatment of dissection and transection in the United States.

Key Takeaways From the Endovascular Aneurysm Repair Devices Market Report Study:

• Market size analysis for current endovascular aneurysm repair devices size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the endovascular aneurysm repair devices market.
• Various opportunities available for the other competitors in the endovascular aneurysm repair devices market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current endovascular aneurysm repair devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for endovascular aneurysm repair devices market growth in the coming future?

Target Audience Who Can be Benefited From This Endovascular Aneurysm Repair Devices Market Report Study:

• Endovascular aneurysm repair device product providers
• Research organizations and consulting companies 
• Endovascular aneurysm repair devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in endovascular aneurysm repair devices 
• Various end-users who want to know more about the endovascular aneurysm repair devices market and the latest technological developments in the endovascular aneurysm repair devices market.